ACH — Accendra Health Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapContrarian

Annual income statement for Accendra Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	R2023 December 31st	R2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	9,785	9,955	2,553	2,680	2,762
Cost of Revenue
Gross Profit	1,513	1,826	1,217	1,280	1,289
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	9,457	9,813	2,419	2,898	2,735
Operating Profit	328	143	133	-218	27.5
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	277	10.9	15.3	-330	-102
Provision for Income Taxes
Net Income After Taxes	222	22.4	8.9	-351	-103
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	222	22.4	-41.3	-363	-1,101
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	222	22.4	-41.3	-363	-1,101
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.73	0.763	0.75	-1.43	-0.483
Dividends per Share